These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 11535525)

  • 1. Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A; Takei K; Kanegane C; Okada K; Ohta K; Seki H; Igarashi N; Maruhashi K; Katayama K; Katoh E; Terao G; Sakiyama Y; Koizumi S
    Blood; 2001 Sep; 98(6):1882-8. PubMed ID: 11535525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell type specific infection of Epstein-Barr virus (EBV) in EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection.
    Kasahara Y; Yachie A
    Crit Rev Oncol Hematol; 2002 Dec; 44(3):283-94. PubMed ID: 12467968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel mouse xenograft models reveal a critical role of CD4+ T cells in the proliferation of EBV-infected T and NK cells.
    Imadome K; Yajima M; Arai A; Nakazawa A; Kawano F; Ichikawa S; Shimizu N; Yamamoto N; Morio T; Ohga S; Nakamura H; Ito M; Miura O; Komano J; Fujiwara S
    PLoS Pathog; 2011 Oct; 7(10):e1002326. PubMed ID: 22028658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunologic difference between hypersensitivity to mosquito bite and hemophagocytic lymphohistiocytosis associated with Epstein-Barr virus infection.
    Lee WI; Lin JJ; Hsieh MY; Lin SJ; Jaing TH; Chen SH; Hung IJ; Yang CP; Chen CJ; Huang YC; Li SP; Huang JL
    PLoS One; 2013; 8(10):e76711. PubMed ID: 24204658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD95 (Fas) ligand expression of Epstein-Barr virus (EBV)-infected lymphocytes: a possible mechanism of immune evasion in chronic active EBV infection.
    Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
    Pathol Int; 1999 Jan; 49(1):9-13. PubMed ID: 10227719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-Cell Transcriptomic Analysis of Epstein-Barr Virus-Associated Hemophagocytic Lymphohistiocytosis.
    Suzuki T; Sato Y; Okuno Y; Torii Y; Fukuda Y; Haruta K; Yamaguchi M; Kawamura Y; Hama A; Narita A; Muramatsu H; Yoshikawa T; Takahashi Y; Kimura H; Ito Y; Kawada JI
    J Clin Immunol; 2024 Apr; 44(4):103. PubMed ID: 38642164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Case Report: A Case of Epstein-Barr Virus-Associated Acute Liver Failure Requiring Hematopoietic Cell Transplantation After Emergent Liver Transplantation.
    Nakajima K; Hiejima E; Nihira H; Kato K; Honda Y; Izawa K; Kawabata N; Kato I; Ogawa E; Sonoda M; Okamoto T; Okajima H; Yasumi T; Takita J
    Front Immunol; 2022; 13():825806. PubMed ID: 35154146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dominant expression of interleukin-10 and transforming growth factor-beta genes in activated T-cells of chronic active Epstein-Barr virus infection.
    Ohga S; Nomura A; Takada H; Tanaka T; Furuno K; Takahata Y; Kinukawa N; Fukushima N; Imai S; Hara T
    J Med Virol; 2004 Nov; 74(3):449-58. PubMed ID: 15368517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sintilimab treatment for chronic active Epstein-Barr virus infection and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in children.
    Chen R; Lin Q; Zhu Y; Shen Y; Xu Q; Tang H; Cui N; Jiang L; Dai X; Chen W; Li X
    Orphanet J Rare Dis; 2023 Sep; 18(1):297. PubMed ID: 37736751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic Epstein-Barr Virus-Positive T/NK Lymphoproliferative Diseases With
    Ishimura M; Eguchi K; Shiraishi A; Sonoda M; Azuma Y; Yamamoto H; Imadome KI; Ohga S
    Front Pediatr; 2019; 7():183. PubMed ID: 31231620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Characteristics of peripheral blood lymphocyte immune subsets in patients with chronic active Epstein-Barr virus infection].
    Xing Y; Song HM; Li TS; Qiu ZF; Wu XY; Wang W; Wei M
    Zhonghua Er Ke Za Zhi; 2009 Jun; 47(6):441-5. PubMed ID: 19951472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An analysis of immunophenotyping of peripheral lymphocytes in adult patients with infectious mononucleosis and chronic active Epstein-Barr virus infection].
    Xie J; Wang HL; Qiu ZF; Li TS
    Zhonghua Nei Ke Za Zhi; 2016 Jun; 55(6):455-9. PubMed ID: 27256608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
    Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
    J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of cloned expansion and CD5 down-regulation in Epstein-Barr Virus (EBV)-infected CD8+ T lymphocytes in EBV-associated hemophagocytic lymphohistiocytosis.
    Toga A; Wada T; Sakakibara Y; Mase S; Araki R; Tone Y; Toma T; Kurokawa T; Yanagisawa R; Tamura K; Nishida N; Taneichi H; Kanegane H; Yachie A
    J Infect Dis; 2010 Jun; 201(12):1923-32. PubMed ID: 20443735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel animal model of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in humanized mice.
    Sato K; Misawa N; Nie C; Satou Y; Iwakiri D; Matsuoka M; Takahashi R; Kuzushima K; Ito M; Takada K; Koyanagi Y
    Blood; 2011 May; 117(21):5663-73. PubMed ID: 21467545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinicopathological study of severe chronic active Epstein-Barr virus infection that developed in association with lymphoproliferative disorder and/or hemophagocytic syndrome.
    Ohshima K; Suzumiya J; Sugihara M; Nagafuchi S; Ohga S; Kikuchi M
    Pathol Int; 1998 Dec; 48(12):934-43. PubMed ID: 9952337
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymptomatic Primary Infection with Epstein-Barr Virus: Observations on Young Adult Cases.
    Abbott RJ; Pachnio A; Pedroza-Pacheco I; Leese AM; Begum J; Long HM; Croom-Carter D; Stacey A; Moss PAH; Hislop AD; Borrow P; Rickinson AB; Bell AI
    J Virol; 2017 Nov; 91(21):. PubMed ID: 28835490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spectrum of Epstein-Barr virus-associated T-cell lymphoproliferative disorder in adolescents and young adults in Taiwan.
    Wang RC; Chang ST; Hsieh YC; Huang WT; Hsu JD; Tseng CE; Wang MC; Hwang WS; Wang J; Chuang SS
    Int J Clin Exp Pathol; 2014; 7(5):2430-7. PubMed ID: 24966953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathological categorization of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disease: an analysis of 42 cases with an emphasis on prognostic implications.
    Paik JH; Choe JY; Kim H; Lee JO; Kang HJ; Shin HY; Lee DS; Heo DS; Kim CW; Cho KH; Kim TM; Jeon YK
    Leuk Lymphoma; 2017 Jan; 58(1):53-63. PubMed ID: 27157296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epstein-Barr virus (EBV)-induced B-cell proliferative disorder after chemotherapy in a patient with hemophagocytic lymphohistiocytosis with associated EBV-induced T-cell proliferation.
    Suzumiya J; Ohshima K; Kanda M; Kumagawa M; Nagano M; Hirata M; Nawa Y; Tamura K; Kikuchi M
    Leuk Lymphoma; 2000 May; 37(5-6):593-604. PubMed ID: 11042520
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.